ATE97448T1 - Verfahren zur isolierung von ca 125-antigen. - Google Patents

Verfahren zur isolierung von ca 125-antigen.

Info

Publication number
ATE97448T1
ATE97448T1 AT87908082T AT87908082T ATE97448T1 AT E97448 T1 ATE97448 T1 AT E97448T1 AT 87908082 T AT87908082 T AT 87908082T AT 87908082 T AT87908082 T AT 87908082T AT E97448 T1 ATE97448 T1 AT E97448T1
Authority
AT
Austria
Prior art keywords
antigen
isolation
procedure
isolated
glycoprotein
Prior art date
Application number
AT87908082T
Other languages
English (en)
Inventor
Hugh M Davis
Thomas L Klug
Vincent R Zurawski Jr
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25464497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE97448(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc filed Critical Centocor Inc
Application granted granted Critical
Publication of ATE97448T1 publication Critical patent/ATE97448T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Magnetic Heads (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
AT87908082T 1986-11-24 1987-11-20 Verfahren zur isolierung von ca 125-antigen. ATE97448T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/933,784 US5059680A (en) 1986-11-24 1986-11-24 Method of isolating ca 125 antigen
EP87908082A EP0332651B2 (de) 1986-11-24 1987-11-20 Verfahren zur isolierung von ca 125-antigen
PCT/US1987/003052 WO1988003954A1 (en) 1986-11-24 1987-11-20 Method of isolating ca 125 antigen

Publications (1)

Publication Number Publication Date
ATE97448T1 true ATE97448T1 (de) 1993-12-15

Family

ID=25464497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87908082T ATE97448T1 (de) 1986-11-24 1987-11-20 Verfahren zur isolierung von ca 125-antigen.

Country Status (7)

Country Link
US (1) US5059680A (de)
EP (1) EP0332651B2 (de)
JP (1) JPH02501258A (de)
AT (1) ATE97448T1 (de)
CA (1) CA1305416C (de)
DE (1) DE3788229T3 (de)
WO (1) WO1988003954A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5976818A (en) * 1991-12-16 1999-11-02 The Board Of Trustees Of The University Of Arkansas Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
EP0957749A2 (de) * 1995-09-12 1999-11-24 The General Hospital Corporation Verfahren zur früherkennung des eierstockrebs
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
US7318921B2 (en) 1996-05-15 2008-01-15 Altarex Medical Corp. Therapeutic compositions that alter the immune response
IL139700A (en) 1998-06-15 2005-09-25 Altarex Medical Corp Immunotherapeutic composition for the treatment of prostate cancer
US6376654B1 (en) * 1999-08-13 2002-04-23 Molecular Discoveries, Llc Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US7226750B1 (en) 2000-08-08 2007-06-05 Molecular Discoveries, Inc. Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
WO2002020620A2 (en) * 2000-09-05 2002-03-14 Medical Research Council Monoclonal antibody against ovarian carcinoma
SI2301965T1 (sl) 2002-10-16 2015-07-31 Purdue Pharma L.P. Protitelesa, ki vežejo celično- povezan CA 125 / O722P in metode uporabe le-teh
US7682794B2 (en) * 2003-07-15 2010-03-23 The Regents Of The University Of California Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
ES2941897T3 (es) 2014-11-12 2023-05-26 Seagen Inc Compuestos que interaccionan con glicanos y procedimientos de uso
AU2016353153B2 (en) 2015-11-12 2023-11-23 Seagen Inc. Glycan-interacting compounds and methods of use
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
SG11201907889YA (en) 2017-03-03 2019-09-27 Seattle Genetics Inc Glycan-interacting compounds and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2630380A1 (de) * 1975-07-14 1977-02-03 Microlog Ltd Verfahren zur herstellung einer vakzine
US4584278A (en) * 1982-03-19 1986-04-22 University Of Rochester Antigen derived from human ovarian tumors and radioimmunoassay using the antigen
JPS60256284A (ja) * 1984-06-01 1985-12-17 Nippon Telegr & Teleph Corp <Ntt> 動画像送受信方式

Also Published As

Publication number Publication date
EP0332651A1 (de) 1989-09-20
EP0332651B1 (de) 1993-11-18
US5059680A (en) 1991-10-22
CA1305416C (en) 1992-07-21
WO1988003954A1 (en) 1988-06-02
EP0332651B2 (de) 1996-12-27
DE3788229D1 (de) 1993-12-23
DE3788229T2 (de) 1994-04-21
JPH02501258A (ja) 1990-05-10
DE3788229T3 (de) 1997-04-10

Similar Documents

Publication Publication Date Title
ATE97448T1 (de) Verfahren zur isolierung von ca 125-antigen.
FI852522A0 (fi) Menetelmä tymopentiinianalogien valmistamiseksi
CA1262357A (en) N-HYDROXYL PROTECTIVE GROUPS AND METHOD FOR THE PREPARATION OF 3-ACYLAMINO-1-HYDROXY-2-AZETIDINONES
NO931153D0 (no) Vannloeselige comptothecin-analoger fremgangsmaater og metoder
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
EP0165033A3 (de) Verbindungen von Thymopentin-Type mit konformationäler Beschränkung
PT87055A (pt) Process of genetic engineering for the preparation of molecular markers
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DE3689196D1 (de) Verfahren zur Herstellung von Amiden unter Verwendung von Mikroorganismen.
ATE41034T1 (de) Herstellung von protein a.
DE3788742D1 (de) Verfahren zur Herstellung von Blockcopolymeren.
DE3854598D1 (de) Verfahren zur Herstellung von radialen, asymmetrischen Copolymeren.
DK450785A (da) Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed
ATE30049T1 (de) Verfahren zur herstellung von d-milchsaeure unter verwendung von lactobacillus bulgaricus dsm 2129.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
DK396685A (da) Fremgangsmaade til mekanisk oplukning af bakterieceller til isolering af peptider
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
EP0255717A3 (de) Gangliosid-Derivate und Verfahren zur Herstellung davon
ATE19623T1 (de) Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.
DE3677838D1 (de) Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure.
ATE248914T1 (de) Allogenes vakzin und synthesemethode für selbiges
ATE127159T1 (de) Verfahren zur racemattrennung von 4-aryl-2-oxo- pyrrolidin-3-carbonsäure-estern.
DE3764492D1 (de) Verfahren zur herstellung von als adjuvans fuer detergentien verwendbaren oxodisuccinaten.
DE58901794D1 (de) Verfahren zur herstellung von tert.-olefinen.
DE3775774D1 (de) Verfahren zur herstellung von alkyl-tert-butylaethern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties